According to Medifast's latest financial reports the company has $0.20 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.20 B | 29.95% |
2022-12-31 | $0.15 B | -23.43% |
2021-12-31 | $0.20 B | 28.76% |
2020-12-31 | $0.15 B | 50% |
2019-12-31 | $0.10 B | -3.92% |
2018-12-31 | $0.10 B | 0.48% |
2017-12-31 | $0.10 B | 13.09% |
2016-12-31 | $96.01 M | 8.39% |
2015-12-31 | $88.58 M | 10.08% |
2014-12-31 | $80.47 M | -18.23% |
2013-12-31 | $98.41 M | 8.4% |
2012-12-31 | $90.78 M | 23.68% |
2011-12-31 | $73.4 M | 2.01% |
2010-12-31 | $71.95 M | 50.48% |
2009-12-31 | $47.81 M | 35.76% |
2008-12-31 | $35.22 M | 8.64% |
2007-12-31 | $32.42 M | 16.13% |
2006-12-31 | $27.91 M | 26.77% |
2005-12-31 | $22.02 M | 14.66% |
2004-12-31 | $19.2 M | 12.47% |
2003-12-31 | $17.07 M | 206.15% |
2002-12-31 | $5.57 M | 119.78% |
2001-12-31 | $2.53 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $1.38 B | 589.50% | ๐บ๐ธ USA |
Abeona Therapeutics
ABEO | $14.82 M | -92.64% | ๐บ๐ธ USA |
Bellerophon Therapeutics
BLPH | $3.72 M | -98.15% | ๐บ๐ธ USA |